Organigram Global Inc. OGI
1.10
0.00
0.00%
as of 25 Sep
- Market cap
- $155.1M
- P/E
- 2.4×
Follow OGI
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
2.19 | 0.00 | 12.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.62 | 0.89 | 1.13 | 1.40 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(46.67) | (34.48) | (19.73) | (262.25) | |
P/B ratio |
0.39 | 0.65 | 0.86 | 1.04 | |
Price to Tangible BV |
2.19 | 0.86 | 1.17 | 1.46 | |
EV/Sales |
0.65 | 0.69 | 0.91 | 1.07 | |
EV/EBITDA |
15.62 | 0.00 | 20.89 | 104.00 | |
EV/Operating CF |
(7.04) | (18.04) | (13.03) | (36.65) | |
EV/FCF |
(6.84) | (8.68) | (6.88) | (11.34) | |
Quick Ratio |
0.93 | 1.22 | 1.20 | 1.18 | |
Current Ratio |
2.61 | 2.82 | 2.73 | 2.26 | |
Net Debt/EBITDA |
0.61 | 3.69 | (40.31) | (7.69) | |
Debt/Assets |
2.56% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.04 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.45 | 0.53 | 0.55 | 0.53 | |
Operating CF/Net income |
(0.04) | 7.62 | (0.80) | 0.04 | |
Capex/Depreciation |
0.05 | (0.05) | (0.42) | 0.22 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
2.09% | 3.39% | 3.28% | 3.94% | |
Selling, General and Administrative Expense of Revenue |
32.03% | 40.43% | 38.79% | 34.36% | |
Intangible Assets out of Total Assets |
0.49 | 0.18 | 0.19 | 0.18 | |
Share Based Compensation of Revenue |
1.13% | 1.24% | 1.21% | 1.12% | |
Graham Net Nets |
(0.29) | 0.42 | 0.30 | 0.20 | |
Graham Number |
5.21 | 0.00 | 2.49 | 0.00 | |
Earnings Yield |
45.58% | (9.34%) | 8.33% | (5.42%) | |
Free Cash Flow Yield |
(15.34%) | (8.91%) | (11.64%) | (6.77%) | |
Revenue per Share |
0.57 | 0.33 | 0.34 | 0.45 | |
Operating CF per Share |
(0.02) | (0.04) | (0.09) | (0.01) | |
Capex per Share |
0.00 | 0.00 | (0.01) | 0.01 | |
Free Cash Flow per Share |
(0.02) | (0.04) | (0.10) | 0.00 | |
Cash per Share |
0.06 | 0.30 | 0.33 | 0.47 | |
Shareholders Equity per Share |
2.59 | 2.06 | 1.96 | 1.95 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.59 | 2.06 | 1.96 | 1.95 | |
Free Cash Flow |
(2.63) | (5.32) | (13.00) | (0.22) | |
Working Capital |
124.82 | 117.60 | 116.56 | 113.48 | |
Capital Expenditures |
0.33 | (0.20) | (1.51) | 0.77 | |
Net Current Asset Value |
(39.52) | 73.32 | 68.38 | 51.34 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.03 | (0.01) | |
Net Profit Margin |
99.77% | (1.54%) | 31.43% | (45.45%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
52.80 | 36.86 | 34.73 | 36.84 | |
Average Payables |
68.55 | 48.59 | 48.11 | 49.21 | |
Average Inventory |
104.86 | 89.32 | 84.72 | 74.63 | |
Average Assets |
500.35 | 377.29 | 361.45 | 350.83 | |
Average Common Equity |
314.68 | 271.50 | 248.08 | 237.23 |
Columns are period end dates